Study Finds Little Difference Between Diabetes Drugs’ Effectiveness
The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.
Tag Archives: Januvia
-
-
Sulphonylureas Linked To Higher Risk of Hypoglycemia: Study
A popular class of diabetes drugs may be causing blood glucose levels to drop too low in some diabetics, resulting in an increased risk of hypoglycemic health problems, according to…
-
Onglyza, Januvia Not Linked To Increased Heart Failure Risk: Study
Two new studies find no evidence of heart failure risk associated with Onglyza and Januvia, contradicting some previous studies and an FDA warning.
-
Problems Combining Onglyza, Januvia With Sulphonylureas May Increase Risk Of Low Blood Sugar: Study
Combining Januvia and Onglyza with certain other diabetes drugs could result in dangerously low blood glucose levels, according to the findings of a new study.
-
Heart Risks with Onglyza, Januvia Questioned By New Study
A new study failed to find any link between Onglyza, Januvia and similar diabetes drugs and an increased risk of heart failure.
-
Invokana Study Claims Superiority over Januvia, Despite Ketoacidosis, Kidney Injury Risks
A new study indicates that Invokana is more effective than Januvia at helping to meet blood glucose goals, but the drug is plagued with concerns over diabetic ketoacidosis and kidney…
-
Diabetes Drug Pancreatic Cancer Lawsuits Dismissed on Preemption Grounds
A federal judge has granted summary judgment in the federal litigation over incretin mimetic diabetes drugs, which alleged that inadequate warnings were provided about the risk of pancreatic cancer from…
-
Januvia Joint Pain Problems Result in FDA Warning for Class of Diabetes Drugs
The FDA is warning that Januvia and similar diabetes drugs may be causing cases of severe joint pain among users.
-
Some Diabetes Drugs May Increase Heart Disease Risks, Researcher Warns
Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to…
-
Onglyza Risks Lead Express Scripts to Drop Drug from 2016 Formulary
Onglyza and several other drugs have been dropped from Express Scripts insurance coverage lists due to health concerns and the presence of safer, affordable alternatives.
